Table 1.
Demographic, metabolic, serum liver-indices and ultrasonic data obtained before and after treatment in enrolled subjects (mean ± SD)
| Variables | Before | After | P value |
| Age (yr) | 44 ± 3.2 | ||
| Sex (M/F) | 40/32 | ||
| BMI (kg/m2) | 26.7 ± 1.67 | 26.4 ± 1.34 | NS |
| Fasting plasma glucose (mg/mL) | 105.7 ± 0.8 | 101 ± 0.5 | NS |
| HOMA-IR | 6.42 ± 0.4 | 5.27 ± 1.2 | NS |
| Total Cholesterol (mg/dL) | 205.7 ± 9.3 | 200.6 ± 8.1 | NS |
| LDL-C (mg/mL) | 157.4 ± 4.3 | 136 ± 1.8 | NS |
| HDL-C (mg/mL) | 43.6 ± 2.1 | 45.8 ± 1.1 | NS |
| Triglycerides (mg/mL) | 178.4 ± 4.1 | 155.7 ± 3.4 | NS |
| Steato test | 0.71 ± 0.07 | 0.40 ± 0.05 | < 0.001 |
| ALT (U/L) | 109.48 ± 4.4 | 75.12 ± 3.3 | < 0.01 |
| AST (U/L) | 72.39 ± 8.4 | 48.65 ± 3.2 | < 0.01 |
| AST/ALT ratio | 0.66 ± 0.4 | 0.64 ± 0.9 | NS |
| γ-GT (IU/L) | 45.51 ± 1.2 | 29.33 ± 1.1 | < 0.001 |
| TNF-α (pg/mL) | 16.2 ± 0.9 | 9.7 ± 0.7 | < 0.001 |
| Hepatorenal ratio | 2.5 ± 0.3 | 1.8 ± 0.6 | < 0.05 |
M/F: Male/female; BMI: Body mass index; HOMA-IR: Homeostatic model assessment insulin resistance; LDL: Low density lipoprotein; HDL: High density lipoprotein; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; γ-GT: Gamma glutamyl transpeptidase; TNF-α: Tumor necrosis factor-α; NS: Not significant.